For the fourth year running, we’ve been included! 💫

Success in this industry isn't about one cycle. It's about longevity and the depth of partnerships built over years, through the ups and downs of the market.

We need new paradigms for the research enterprise, including innovative models for funding and sharing scientific research, redefining how America conducts the business of discovery. We must build an ecosystem that attracts top talent, celebrates merit, protects our intellectual edge, and enables scientists to focus on meaningful work rather than administrative box checking.

Our federal agencies distribute approximately $200 billion in annual R&D funding. Yet we have no systematic framework for identifying where those dollars could catalyze the greatest scientific returns, with deference instead given to the same incumbents that consume the funding.

Driving meaningful improvements in our portfolio allocation will require a coordinated effort, but it is not impossible. We already have proof that bold models can dramatically accelerate progress and deliver new scientific opportunities for our researchers.

“The Clarity Act — like all legislation — is not perfect. And there are lots of things that you could debate and argue about. But I think one of the most important things that it does is that it creates a level playing field to enhance market stability and allow these markets to develop appropriately,” Solomon said in an interview.

“I’m very supportive of moving the Clarity Act forward, so we can get some market structure in place and start to move the innovation process along,” he said.